Author

A. Singal

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease.

Importance Although metabolic dysfunction-associated steatotic liver disease (MASLD) is traditionally associated with obesity, it is increasingly recognized in individuals with normal weight (ie, lean MASLD). Objective To characterize the clinical, histologic, and prognostic features of lean MASLD, and evaluate the p...

L. de Avila, K. Al-Naamani, M. Papatheodoridi et al. · Journal of the American Medi... · 1 citation

Review Open access Sep 2026

Therapeutic modulation of the gut-brain axis in alcohol use disorder: A systematic review

Background Alcohol Use Disorder (AUD) involves gut-brain axis dysfunction. Modulating microbiota offers a promising therapeutic strategy. Methods Clinical trials on fecal microbiota transplant (FMT), prebiotics (inulin), probiotics, and neurohormonal agents like glucagon-like peptide-1 (GLP-1) and ghrelin receptor anta...

Prabha Bhandari, Abdelhaleem Sideeg, Mohamed A. Elfeki et al. · Metabolism Open · 0 citations

Review Open access Sep 2026

Steatosis Liver Index: A Validated Machine Learning Model Using Clinical Data Distinguishes Steatotic Liver Disease Phenotypes

Introduction and Objectives: Steatotic liver disease (SLD) is a leading cause of liver disease worldwide. Itsstratified into metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol-associated liver disease (MetALD), and alcohol-associated liver disease (ALD) based on self-rep...

Mangesh Pagadala, Talal Khurshid, Wan-Yu Zhang et al. · Digestive and Liver Disease · 2 citations